STOCKHOLM, SE / ACCESSWIRE / September 09, 2024 / iZafe Group (STO:IZAFE-B) iZafe Group AB ("iZafe Group") today announces a...
LONDON, UNITED KINGDOM / ACCESSWIRE / September 9, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), a clinical-stage biopharmaceutical group focused on...
CALGARY, Alberta, Sept. 06, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX...
NAARDEN, the Netherlands and MIAMI, Sept. 06, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or...
TORONTO, ON / ACCESSWIRE / September 6, 2024 / Quantum BioPharma Ltd. (formerly, FSD Pharma Inc.) (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or...
NEW YORK, Sept. 6, 2024 /PRNewswire/ -- Report with market evolution powered by AI- The global mass spectrometry market size...
Trusted Partner: The company serves more than 300 hospitals, pharmaceuticals, clinics, and biotech companies, securing their critical data and applications....
TEMPE, Ariz., Sept. 6, 2024 /PRNewswire/ -- Economic activity in the hospital subsector grew in August for the 12th consecutive month...
Strategic collaboration strengthens end-to-end connectivity & data flow across the drug development platform, ensuring seamless interoperability across Clinical, Safety, Regulatory,...
WASHINGTON, Sept. 06, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60P” or the “Company”), a pharmaceutical...
Results from this trial are expected in 2025SAN DIEGO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX)...
The companies share how their collaboration enables clinical trial enrollment for a novel cancer therapy for oncogene amplified cancers in...
LONDON, Sept. 5, 2024 /PRNewswire/ -- Coronado Research is a consultancy-led professional services organisation operating in the clinical development arena. The...
Industry Conference Focused on Overcoming Healthcare Policy, Economic, and Business Hurdles in Go-to-Market Decisioning and Net Revenue Optimization PHILADELPHIA, Sept....
New capabilities and simple, standard site experience cut trial time and expense Fixed price implementation to get up and running...
Outgoing CEO, Chris Bunka, to remain on as Chairman of the Board of Directors and Executive Strategic Advisor KELOWNA, BC...
Company's Canalevia®-CA1 prescription drug is FDA conditionally approved for treatment of chemotherapy-induced diarrhea (CID) in dogs and is the first...
Suite of expansive solutions delivers even more access to patients at the right time in the right way to drive...
LA JOLLA, CA, Sept. 05, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a...
BASKING RIDGE, N.J., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage...